BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17080242)

  • 1. Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer.
    Gu J; Yamamoto H; Fukunaga H; Danno K; Takemasa I; Ikeda M; Tatsumi M; Sekimoto M; Hatazawa J; Nishimura T; Monden M
    Dig Dis Sci; 2006 Dec; 51(12):2198-205. PubMed ID: 17080242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of [
    Jiang H; Zhang R; Jiang H; Zhang M; Guo W; Feng G; Pan W; Xu H; Wang S
    Nucl Med Biol; 2019; 72-73():36-44. PubMed ID: 31330410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism underlying the detection of colorectal cancer by 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography.
    Izuishi K; Yamamoto Y; Sano T; Takebayashi R; Nishiyama Y; Mori H; Masaki T; Morishita A; Suzuki Y
    J Gastrointest Surg; 2012 Feb; 16(2):394-400. PubMed ID: 22065316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression.
    Yamada A; Oguchi K; Fukushima M; Imai Y; Kadoya M
    Ann Nucl Med; 2006 Nov; 20(9):597-604. PubMed ID: 17294670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Glut-1 in primary and recurrent head and neck squamous cell carcinomas, and compared with 2-[18F]fluoro-2-deoxy-D-glucose accumulation in positron emission tomography.
    Li SJ; Guo W; Ren GX; Huang G; Chen T; Song SL
    Br J Oral Maxillofac Surg; 2008 Apr; 46(3):180-186. PubMed ID: 18093707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of SUVmax and GLUT-1 Expression in Determining Tumor Aggressiveness in Patients With Clinical Stage I Endometrioid Endometrial Cancer.
    Lee DW; Chong GO; Lee YH; Hong DG; Cho YL; Jeong SY; Park JY; Lee YS
    Int J Gynecol Cancer; 2015 Jun; 25(5):843-9. PubMed ID: 25347093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of Glut-1 glucose transporter expression with.
    Higashi K; Ueda Y; Sakurai A; Wang XM; Xu L; Murakami M; Seki H; Oguchi M; Taki S; Nambu Y; Tonami H; Katsuda S; Yamamoto I
    Eur J Nucl Med; 2000 Dec; 27(12):1778-85. PubMed ID: 11189940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorine-18-fluorodeoxyglucose uptake of bone marrow on PET/CT can predict prognosis in patients with colorectal cancer after curative surgical resection.
    Lee JW; Baek MJ; Ahn TS; Lee SM
    Eur J Gastroenterol Hepatol; 2018 Feb; 30(2):187-194. PubMed ID: 29120905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ¹⁸F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma.
    Hong R; Lim SC
    World J Gastroenterol; 2012 Jan; 18(2):168-74. PubMed ID: 22253523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study.
    Tian M; Zhang H; Nakasone Y; Mogi K; Endo K
    Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):5-12. PubMed ID: 14551748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glut-1 expression and enhanced glucose metabolism are associated with tumour grade in bone and soft tissue sarcomas: a prospective evaluation by [18F]fluorodeoxyglucose positron emission tomography.
    Tateishi U; Yamaguchi U; Seki K; Terauchi T; Arai Y; Hasegawa T
    Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):683-91. PubMed ID: 16506050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG-PET reflects tumor viability on SUV in colorectal cancer liver metastasis.
    Watanabe A; Harimoto N; Yokobori T; Araki K; Kubo N; Igarashi T; Tsukagoshi M; Ishii N; Yamanaka T; Handa T; Oyama T; Higuchi T; Shirabe K
    Int J Clin Oncol; 2020 Feb; 25(2):322-329. PubMed ID: 31612350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors.
    Higashi T; Tamaki N; Torizuka T; Nakamoto Y; Sakahara H; Kimura T; Honda T; Inokuma T; Katsushima S; Ohshio G; Imamura M; Konishi J
    J Nucl Med; 1998 Oct; 39(10):1727-35. PubMed ID: 9776278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging features of colorectal liver metastasis in FDG PET-CT: a retrospective correlative analysis between CT attenuation and FDG uptake.
    Au-Yeung AW; Luk WH; Lo AX
    Nucl Med Commun; 2012 Apr; 33(4):403-7. PubMed ID: 22273638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BATF promotes tumor progression and association with FDG PET-derived parameters in colorectal cancer.
    Lu X; Liu J; Feng L; Huang Y; Xu Y; Li C; Wang W; Kan Y; Yang J; Zhang M
    J Transl Med; 2024 Jun; 22(1):558. PubMed ID: 38862971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility of functional volume and activity concentration in 18F-FDG PET/CT of liver metastases in colorectal cancer.
    Heijmen L; de Geus-Oei LF; de Wilt JH; Visvikis D; Hatt M; Visser EP; Bussink J; Punt CJ; Oyen WJ; van Laarhoven HW
    Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1858-67. PubMed ID: 22945372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer.
    van Baardwijk A; Dooms C; van Suylen RJ; Verbeken E; Hochstenbag M; Dehing-Oberije C; Rupa D; Pastorekova S; Stroobants S; Buell U; Lambin P; Vansteenkiste J; De Ruysscher D
    Eur J Cancer; 2007 Jun; 43(9):1392-8. PubMed ID: 17512190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.
    Kato H; Takita J; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
    Anticancer Res; 2003; 23(4):3263-72. PubMed ID: 12926062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression.
    Yen TC; See LC; Lai CH; Yah-Huei CW; Ng KK; Ma SY; Lin WJ; Chen JT; Chen WJ; Lai CR; Hsueh S
    J Nucl Med; 2004 Jan; 45(1):22-9. PubMed ID: 14734665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.